Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Sight Sciences Inc (SGHT) USD0.001

Sell:$24.62 Buy:$24.74 Change: $0.60 (2.38%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Change: $0.60 (2.38%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Change: $0.60 (2.38%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Sight Sciences, Inc. is an ophthalmic medical device company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company’s surgical glaucoma product portfolio features the OMNI surgical system (OMNI), a device that facilitates the performance of both trabeculotomy and canaloplasty with a single device and single corneal incision. Its nonsurgical dry eye product portfolio consists of the TearCare system for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids. The Company has two reportable segments: Surgical Glaucoma and Dry Eye. Its Surgical Glaucoma segment consists of sales of the OMNI surgical system. Its Dry Eye segment includes sales of the TearCare system and related components and accessories. The Company primarily sell both the systems through a direct sales model.

Contact details

3000 Sand Hill Road
Building 3, Suite 105
United States
+1 (415) 8890550

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.20 billion
Shares in issue:
47.27 million
Health Care Equipment
United States
US dollar

Key personnel

  • Paul Badawi
    Chief Executive Officer, Founder, Director
  • David Badawi
    Founder, Chief Technology Officer, Director
  • Jesse Selnick
    Chief Financial Officer
  • Ingrid Kane
    Vice President - Global Medical Affairs
  • John Ordway
    Vice President - Global Supply Chain

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.